Skip to Content

CRISPR Therapeutics

CRSP

Buy $CRSP at eToro
Rank 2079
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address BAARERSTRASSE 14, ZUG, CH

CRISPR Therapeutics - Key figures

Market cap 4.85 Billion
Revenue 915.36 Million
Profit 476.33 Million
P/E Ratio 16.21
P/s Ratio 5.29
Buy $CRSP at eToro

CRISPR Therapeutics - Description

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.

The company is headquartered in Zug, Switzerland.